Vasculitis and Giant Cell Arteritis

Top Story

BMI changes, glucocorticoid exposure improve AAV disease activity

BMI changes, glucocorticoid exposure improve AAV disease activity
June 28, 2017

Among patients with antineutrophil cytoplasmic antibody-associated vasculitis, changes in BMI and glucocorticoid exposure were linked to improvements in disease activity, according to a published analysis.

John H. Stone, MD, MPH, director of clinical rheumatology at Massachusetts General Hospital, and colleagues assessed 197 patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who participated in the RAVE trial.

Meeting News

Elevated stroke, myocardial infarction risks found for patients with ANCA-associated vasculitis

June 20, 2017
MADRID — ANCA-associated vasculitis demonstrated a significant association with stroke risk and a trend toward myocardial infarction, according to findings…
Meeting News

Rituximab pharmacokinetics not associated with response in ANCA-associated vasculitis

June 19, 2017
MADRID — No association was observed between pharmacokinetic levels of rituximab and clinical response in patients with ANCA-associated vasculitis, according to
Feature

Unspoken and Undiagnosed: Addressing Sex and Intimacy Issues in Rheumatic Disease

Healio Rheumatology, June 2017
Sexual dysfunction and intimacy issues may rank high among the complaints reported by patients with rheumatic diseases, but these complaints often remain unaddressed in…
CME

Giant Cell Arteritis: New Findings on Diagnostic Strategies and Emerging Therapies

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis is a potentially debilitating rheumatologic disease that afflicts predominantly older men and…
More »
Video
Meeting News Coverage

VIDEO: Adler discusses tocilizumab to treat giant cell arteritis

December 2, 2015
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

ANCA-associated Vasculitis: Cross-disciplinary Considerations to Optimize Patient Care

This activity is supported by an educational grant from Genentech, Inc.

Diagnosis and management of ANCA-associated vasculitis (AAV) presents substantial diagnostic and therapeutic…
More »
Advertisement
Advertisement